GEKA Gesellschaft fuer Experimentelle und Klinische Atemwegsforschung mbH — Clinical Trial Site

7 Registered trials

3 Currently recruiting

Organisation

GEKA Gesellschaft fuer Experimentelle und Klinische Atemwegsforschung mbH

Location

Wiesbaden, Germany

Identifier

ORG-100049691

Address

Berta Cramer Ring 30, 65205, Germany

Departments

n/a
NA
Studienzentrum
Zentrum fuer Rhinologie und Allergologie
Zentrum fuer Rhinologie und Allergologie - Wiesbaden
Zentrum für Rhinologie und Allergologie

Clinical trials at this site (7)

Search interface

Randomised efficacy and safety clinical trial of PQ Birch in subjects with seasonal allergic rhinitis and/or rhinoconjunctivitis induced by … Pending

2023-507427-28-00 seasonal allergic rhinitis and/or rhinoconjunctivitis 5
An extension study to investigate the long-term safety and tolerability of itepekimab in adult participants with inadequately controlled chr… Pending

2025-522983-33-00 Chronic rhinosinusitis with nasal polyps 5
A prospective, randomized, double-blind, placebo-controlled, multicentre, dose-finding clinical trial with polymerised mannan-conjugated all… Recruiting

2025-524580-21-00 Grass pollen induced allergic rhinitis or rhinoconjunct 10 2026-06-01
A study to investigate changes in symptoms in adult participants with chronic rhinosinusitis with nasal polyposis initiating treatment with … Recruiting

2024-513862-20-00 Chronic Rhinosinusitis with Nasal Polyposis 5 2025-03-26
A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis Recruiting

2023-508817-18-00 Perennial Allergic Rhinitis (PAR) 5 2024-10-08
A Phase 3 study to assess the efficacy, safety, and tolerability of itepekimab (antiIL33 mAb) in participants with inadequately-controlled… Ended

2024-516814-39-00 Chronic rhinosinusitis with nasal polyps 5 2025-05-20
A Multi-national Phase IIIb Trial to Determine the Safety and Efficacy of STALORAL® Birch 300 IR in Children and Adolescents 5 to 17 Years o… Ended

2023-509833-38-00 Birch Pollen-induced Allergic Rhinoconjunctivitis 5 2023-09-20